InvestorsHub Logo
Followers 12
Posts 399
Boards Moderated 0
Alias Born 02/18/2020

Re: McMagyar post# 64

Tuesday, 05/18/2021 10:11:44 AM

Tuesday, May 18, 2021 10:11:44 AM

Post# of 136
Good news, Another verification their tech works,
Mountain Valley MD Receives Successful Results From BSL-4 COVID-19 Clearance Trial on Three Variants Tested With Ivectosol

-A single dose of 2.5 milligrams per kilogram of Ivectosol™ was effective at interfering with viral replication and driving viral clearance of the B.1.1.7 COVID-19 variant.
-Tests done in vitro showed the same antiviral effect at 5uM Ivectosol™ concentration after 24 hours and again after 48 hours against all three COVID-19 variants tested - the original B.1.1.7 variant, the South African B.1.351 variant, and the P.1 Brazil variant.

Human trials will start quickly in other countries
India is already on their way with testing

Dr. John Clements is Emeritus Professor of Microbiology and Immunology at Tulane University School of Medicine, he needs to find a way to accelerate this in the US and Canada, may need to bring in a partner for US because the fda needs bribes to do anything